LINC00160 mediated paclitaxel‐And doxorubicin‐resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ

Chemoresistance represents a major challenge in breast cancer (BC) treatment. This study aimed to probe the roles of LINC00160 in paclitaxel‐ and doxorubicin‐resistant BC cells. Three pairs of BC and adjacent normal tissue were used for lncRNA microarray analysis. Paclitaxel‐resistant MCF‐7 (MCF‐7/T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huaiguo, Gu, Juan, Zhou, Daoping, Cheng, Wei, Wang, Yueping, Wang, Qingping, Wang, Xuedong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412707/
https://www.ncbi.nlm.nih.gov/pubmed/32652877
http://dx.doi.org/10.1111/jcmm.15487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412707/
https://www.ncbi.nlm.nih.gov/pubmed/32652877
http://dx.doi.org/10.1111/jcmm.15487

Ejemplares similares